salivary duct carcinoma

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers	Digestive System Diseases, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Stomatognathic Diseases, adenocarcinoma, carcinoma, digestive system disorder, epithelial neoplasm, hypertrophic pyloric stenosis, mouth disorder, neoplasm, pyloric stenosis, salivary duct carcinoma, salivary gland basal cell adenocarcinoma, salivary gland cancer, salivary gland disorder, stomach disorder	Active, not recruiting	Phase 2	2026-10-07		NCT02749903
Phase II Dutasteride in Combination With CAB vs CAB in SDC	salivary duct carcinoma	Recruiting	Phase 2	2025-06-04		NCT05513365

Clinical trials